Malta - English - Medicines Authority

sigillata limited (ireland) inniscarra, main street, rathcoole, co. dublin d24 e029 , ireland - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 2 mg - antiemetics and antinauseants

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - granisetron hydrochloride - concentrate for solution for injection - 3mg/3ml - serotonin (5ht3) antagonists; granisetron

United States - English - NLM (National Library of Medicine)

wockhardt limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. it is not known whether granisetron is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when granisetron hydrochloride injection is administered to a nursing woman. chemotherapy-induced nausea and vomiting [see dosage and administration (2)]  for use in chemotherapy-induced nausea and vomiting in pediatric patients 2 to 16 years of age. safety and effectiveness in pediatric patients under 2 years of age have not been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sodium hydroxide; water for injections; lactic acid; sorbitol - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sorbitol; lactic acid; water for injections; sodium hydroxide - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: sorbitol; hydrochloric acid; water for injections; sodium hydroxide; lactic acid - camptosar is indicated as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum and is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

devatis limited - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg - solution for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults for the prevention of nausea and vomiting induced by cytotoxic chemotherapy in children

United States - English - NLM (National Library of Medicine)

bionpharma inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 1 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 3 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron